Elena Pieri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elena Pieri has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Francesca Maestrelli
Department of Chemistry, School of Sciences of Human Health, University of Florence, via Schiff 6, Sesto Fiorentino, 50019 Florence, Italy
1 shared publication - Letizia Gai
Department of Chemistry (DICUS), School of Sciences of Human Health, University of Florence, Via Ugo Schiff, 6, Sesto F.no, 50019 Florence, Italy
1 shared publication - Marzia Cirri
Department of Chemistry, School of Sciences of Human Health, University of Florence, via Schiff 6, Sesto Fiorentino, 50019 Florence, Italy
1 shared publication - Natascia Mennini
Department of Chemistry, School of Sciences of Human Health, University of Florence, via Schiff 6, Sesto Fiorentino, 50019 Florence, Italy
1 shared publication - Paola Mura
Department of Chemistry (DICUS), School of Sciences of Human Health, University of Florence, Via Ugo Schiff, 6, Sesto F.no, 50019 Florence, Italy
1 shared publication - Riccardo Mattagli
Department of Chemistry (DICUS), School of Sciences of Human Health, University of Florence, Via Ugo Schiff, 6, Sesto F.no, 50019 Florence, Italy
1 shared publication
Latest Publications
- Open Access
Development and Characterization of a Dual-Drug Thermosensitive Mucoadhesive Hydrogel for the Local Treatment of Pediatric Oral Mucositis
Severe oral mucositis requires local treatments that relieve pain, limit microbial proliferation, and support mucosal repair while minimizing exposure to potentially harmful excipients, particularly in pediatric patients. This study aimed to develop thermosensitive mucoadhesive gels co-loaded with lidocaine hydrochloride (2% w/v) and chlorhexidine digluconate (0.2% w/v) for localized buccal therapy. Poloxamer 407 was combined with hyaluronic acid sodium salt, xanthan gum, Carbopol 934, or hydroxypropylmethylcellulose (HPMC). Formulations containing lidocaine alone or both drugs were compared to assess the influence of chlorhexidine addition. Following preliminary screening based on pH and gelation properties, selected formulations were characterized for technological, mucoadhesive, biopharmaceutical, stability, and antibacterial properties. Poloxamer 407 concentration was the main factor governing gel performance, whereas the mucoadhesive polymer primarily affected specific technological attributes. Chlorhexidine incorporation did not compromise overall gel performance, preserving antibacterial activity. The gels exhibited suitable gelation, spreadability, mucoadhesion, residence time, and release properties with negligible membrane permeation. The dual-drug formulation containing 20% poloxamer 407 and 0.50% HPMC emerged as the most promising one, combining appropriate mechanical properties, drug release, antibacterial efficacy, and storage stability. Overall, these findings support dual-drug thermosensitive mucoadhesive gels as a feasible strategy for the local management of severe oral mucositis, especially in pediatrics.
Open AccessDevelopment and Characterization of a Dual-Drug Thermosensitive Mucoadhesive Hydrogel for the Local Treatment of Pediatric Oral Mucositis
Severe oral mucositis requires local treatments that relieve pain, limit microbial proliferation, and support mucosal repair while minimizing exposure to potentially harmful excipients, particularly in pediatric patients. This study aimed to develop thermosensitive mucoadhesive gels co-loaded with lidocaine hydrochloride (2% w/v) and chlorhexidine digluconate (0.2% w/v) for localized buccal therapy. Poloxamer 407 was combined with hyaluronic acid sodium salt, xanthan gum, Carbopol 934, or hydroxypropylmethylcellulose (HPMC). Formulations containing lidocaine alone or both drugs were compared to assess the influence of chlorhexidine addition. Following preliminary screening based on pH and gelation properties, selected formulations were characterized for technological, mucoadhesive, biopharmaceutical, stability, and antibacterial properties. Poloxamer 407 concentration was the main factor governing gel performance, whereas the mucoadhesive polymer primarily affected specific technological attributes. Chlorhexidine incorporation did not compromise overall gel performance, preserving antibacterial activity. The gels exhibited suitable gelation, spreadability, mucoadhesion, residence time, and release properties with negligible membrane permeation. The dual-drug formulation containing 20% poloxamer 407 and 0.50% HPMC emerged as the most promising one, combining appropriate mechanical properties, drug release, antibacterial efficacy, and storage stability. Overall, these findings support dual-drug thermosensitive mucoadhesive gels as a feasible strategy for the local management of severe oral mucositis, especially in pediatrics.